Medication alternatives · FDA-sourced
Brovana Alternatives and FDA-Approved Generic Arformoterol
FDA determined Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL to be bioequivalent and therapeutically equivalent to Brovana Inhalation Solution 15 mcg/2 mL. Both labels describe one unit-dose vial by nebulization twice daily for long-term COPD maintenance treatment.
Direct equivalent
Matching Brovana and generic arformoterol dose
FDA determined Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL to be bioequivalent and therapeutically equivalent to Brovana Inhalation Solution at the same strength.
Brovana
15 mcg/2 mL — 1 unit-dose vial by nebulization twice daily
Arformoterol Tartrate Inhalation Solution
15 mcg/2 mL — 1 unit-dose vial by nebulization twice daily
What “equivalent” means here
The FDA designation applies to matching 15 mcg/2 mL arformoterol inhalation solutions. It does not establish equivalence with another LABA, a different nebulized medicine, or a different regimen.
Scheduled maintenance—not rescue
Both products are labeled for long-term, twice-daily COPD maintenance. They are not indicated for sudden breathing symptoms. Patients should follow their prescribed rescue plan and product-specific nebulizer and storage instructions.
Common questions
Brovana and generic arformoterol FAQ
Does Brovana have an FDA-approved generic?
Yes. FDA approved Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL under ANDA 207306 as a generic of Brovana.
Is generic arformoterol equivalent to Brovana?
Yes, for the matching 15 mcg/2 mL inhalation solutions. FDA determined the generic product to be bioequivalent and therapeutically equivalent to Brovana.
What generic arformoterol dose matches Brovana?
The matching products contain 15 mcg of arformoterol in each 2 mL unit-dose vial. The labeled regimen is one vial by nebulization twice daily, morning and evening.
Can Brovana or generic arformoterol treat sudden breathing symptoms?
No. These long-acting medicines are for scheduled COPD maintenance treatment and are not indicated for acute deterioration or acute bronchospasm. Patients should follow their prescribed rescue plan for sudden symptoms.
Do Brovana and generic arformoterol use a nebulizer?
Yes. Each product is a unit-dose inhalation solution administered by nebulization. Patients should follow the product-specific storage, handling, and nebulizer instructions supplied with their prescription.
Primary sources
Evidence used for this page
DailyMed / U.S. National Library of Medicine
Arformoterol Tartrate Inhalation Solution Prescribing Information
Supports generic arformoterol strength, COPD indication, dosing, limitations, and administration.
DailyMed / U.S. National Library of Medicine
BROVANA Prescribing Information
Supports Brovana strength, COPD indication, dosing, limitations, and administration.
U.S. Food and Drug Administration
ANDA 207306 Approval — Arformoterol Tartrate Inhalation Solution
Supports FDA approval and therapeutic equivalence of matching 15 mcg/2 mL products.
U.S. Food and Drug Administration
Orange Book Preface
Supports FDA therapeutic-equivalence definitions and practitioner responsibilities.
Reviewed by PulmTools Editorial Review on August 28, 2026.
Explore respiratory pharmacology →